2024-11-27 - Analysis Report
## UnitedHealth Group Inc. (UNH) Stock Review

**1. Performance vs. S&P 500 (VOO):**

UnitedHealth Group Inc. (UNH) is a diversified healthcare company offering a range of health benefits and services.  Over the period analyzed, UNH significantly outperformed the S&P 500 (VOO).  The cumulative return for UNH is 209.65%, while VOO's is 128.31%.  This represents a difference of 81.3 percentage points.  The relative divergence of 51.3% indicates UNH's performance is in the upper 51st percentile compared to its historical performance relative to the S&P 500.  The provided alpha values consistently exceed 1, confirming superior performance compared to the benchmark. Beta values generally above 1 suggest higher volatility than the market.

**2. Recent Price Movement:**

* **Closing Price:** $605.83 (Last Market: $606.34)
* **5-day Moving Average:** $594.34
* **20-day Moving Average:** $589.62
* **60-day Moving Average:** $584.62

The stock price is currently trading above all three moving averages, suggesting upward momentum.  The relatively small gap between the closing price and the last market price indicates minimal intraday price fluctuation.

**3. Technical Indicators and Expected Return:**

* **RSI (62.55):**  Indicates the stock is neither overbought nor oversold, suggesting a neutral to slightly bullish sentiment.
* **PPO (0.04):** A positive PPO value suggests bullish momentum, though the value is relatively small.
* **20-Day Relative Divergence (+8.7):** Shows short-term upward momentum.
* **Expected Return (169.4%):** This represents a significant projected outperformance of the S&P 500 over the long term (2+ years) if a consistent investment strategy is followed.  This high expected return needs to be considered in context with the risk profile of the stock and potential market fluctuations. The 606.34 price does not suggest extreme volatility (no sudden surges or crashes).


**4. Recent Financial Performance and Outlook:**

The provided earnings data shows fluctuating EPS and relatively consistent revenue growth.  The significant negative EPS in 2024-05-09 requires further investigation to understand the underlying causes.  The most recent EPS of 6.56 is positive and suggests a strong financial outlook, but further analysis is needed to determine whether it meets or exceeds analyst expectations.


| Date       | EPS   | Revenue (B$) | Notes                                   |
|------------|-------|--------------|----------------------------------------|
| 2024-11-04 | 6.56  | 100.82       |                                        |
| 2024-08-09 | 4.58  | 98.86        |                                        |
| 2024-05-09 | -1.53 | 99.80        | Requires further analysis                |
| 2023-11-06 | 6.31  | 92.36        |                                        |
| 2024-11-04 | 6.31  | 92.36        | Duplicate entry â€“ likely a data error |


**6. Financial Information Analysis:**

Revenue remains relatively stable over the provided quarters. Profit margins show some fluctuation but generally remain healthy, exceeding 20% in most quarters.  Equity fluctuates, and ROE displays variability, with both positive and negative values indicating shifts in profitability.  Further analysis would require examining the balance sheet and cash flow statement for a more comprehensive understanding of the financial health of the company.

**7. News and Recent Issues:**

* _[This section requires accessing real-time news sources such as Shacknews and Finbold to provide an accurate summary of recent news, analyst opinions, and market outlook for UNH.  This information is time-sensitive and cannot be provided reliably within this response.]_  Please conduct your own research using these sources.


**8. Overall Analysis:**

UNH has demonstrated strong historical outperformance compared to the S&P 500.  Recent price action suggests upward momentum.  Technical indicators show a neutral to bullish outlook.  While recent earnings data shows some variability, the latest figures are positive.  However, a deeper dive is needed into the Q2 2024 negative EPS.  High expected returns are projected, but risk assessment is essential.  Consult up-to-date news and analyst reports for a complete picture before making any investment decisions.

**9. Disclaimer:** This analysis is for informational purposes only and should not be considered financial advice.  Always conduct thorough due diligence and consult with a qualified financial advisor before making any investment decisions.  The accuracy of this analysis depends on the accuracy of the data provided.
